1. Signaling Pathways
  2. Others
  3. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10876):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-143943S
    Felodipine 3,5-dimethyl ester-13C2,d6
    Felodipine 3,5-dimethyl ester-13C2,d6 is the 13C- and deuterium labeled Felodipine 3,5-dimethyl ester.
    Felodipine 3,5-dimethyl ester-<sup>13</sup>C<sub>2</sub>,d<sub>6</sub>
  • HY-W077226S
    AChE-IN-23-d10
    AChE-IN-23-d10 (4-Amino-Alpha-diethyl amino-o-cresol-d10 (dihydrochloride)) is the deuterium labeled AChE-IN-23 (HY-W077226). AChE-IN-23 (compound 3h) is an acetylcholinesterase (AChE) inhibitor with an IC50 value of 48.3 μM.
    AChE-IN-23-d<sub>10</sub>
  • HY-146793S
    3β-Hydroxy-7-oxocholest-5-enoic acid-d3
    3β-Hydroxy-7-oxocholest-5-enoic acid-d3 is deuterium labeled 3β-Hydroxy-7-oxocholest-5-enoic acid.
    3β-Hydroxy-7-oxocholest-5-enoic acid-d<sub>3</sub>
  • HY-B0693S
    Ranitidine-d6
    Ranitidine-d6 is the deuterium labeled Ranitidine (HY-B0693). Ranitidine is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine antagonizes Histamine (HY-B1204)-induced increases of the guinea-pig isolated rat atrium and Histamine-induced relaxations of the rat isolated uterine horn, with pA2 values of 7.2 and 6.95, respectively. Ranitidine inhibits breast tumor development and spread in mice.
    Ranitidine-d<sub>6</sub>
  • HY-141581S
    Lyso-PAF C-18-d4
    Lyso-PAF C-18-d4 is the deuterium labeled Lyso-PAF C-18.
    Lyso-PAF C-18-d<sub>4</sub>
  • HY-176354S
    KRAS 2B G12V mutant, Arg-13C6,15N4, Lys-13C6,15N2
    KRAS 2B G12V mutant, Arg-13C36, 15N4, Lys-13C6, 15N2 is the 13C- and 15N-labeled KRAS 2B G12V mutant.
    KRAS 2B G12V mutant, Arg-<sup>13</sup>C<sub>6</sub>,<sup>15</sup>N<sub>4</sub>, Lys-<sup>13</sup>C<sub>6</sub>,<sup>15</sup>N<sub>2</sub>
  • HY-B1662S2
    (Rac)-Hexestrol-d6-1
    (Rac)-Hexestrol-d6-1 is the deuterium labeled (Rac)-Hexestrol (HY-W354544). (Rac)-Hexestrol is the racemic form of Hexestrol (HY-B1662). Hexestrol is a synthetic non-steroidal estrogen.
    (Rac)-Hexestrol-d<sub>6</sub>-1
  • HY-N0229S5
    L-Alanine-13C3,15N,d4
    99.7%
    L-Alanine-13C3,15N,d4 is the deuterium, 13C-, and 15-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.
    L-Alanine-<sup>13</sup>C<sub>3</sub>,<sup>15</sup>N,d<sub>4</sub>
  • HY-W705198
    Tert-butyl [1,4'-bipiperidine]-1'-carboxylate-d10
    Tert-butyl [1,4'-bipiperidine]-1'-carboxylate-d10 is the deuterium labeled Tert-butyl [1,4'-bipiperidine]-1'-carboxylate (HY-W293345).
    Tert-butyl [1,4'-bipiperidine]-1'-carboxylate-d<sub>10</sub>
  • HY-17463S1
    Prednisolone-d6
    Prednisolone-d6 is the deuterium labeled Prednisolone (HY-17463). Prednisolone is a potent, orally active corticosteroid and a glucocorticoid. Prednisolone possesses about four times the anti-inflammatory activity of hydrocortisone while causing less salt and water retention. Prednisolone can be used for ocular, anti-inflammatory research.
    Prednisolone-d<sub>6</sub>
  • HY-W723822
    2-Ethylhexanoic acid-d15
    2-Ethylhexanoic acid-d15 is the deuterium labeled 2-Ethylhexanoic acid.
    2-Ethylhexanoic acid-d<sub>15</sub>
  • HY-Y0553S
    4-Fluorobenzyl chloride-d7
    99.7%
    4-Fluorobenzyl chloride-d7 is the deuterium labeled 4-Fluorobenzyl chloride.
    4-Fluorobenzyl chloride-d<sub>7</sub>
  • HY-W700726
    cis-Atovaquone-d5 (contains 10% trans isomer)
    cis-Atovaquone-d5 (contains 10% trans isomer) is the deuterium labeled cis-Atovaquone.
    cis-Atovaquone-d<sub>5</sub> (contains 10% trans isomer)
  • HY-W009538S1
    5'-Deoxy-5-fluorocytidine-13C5
    5'-Deoxy-5-fluorocytidine-13C5 is the 13C labeled isotope of 5'-Deoxy-5-fluorocytidine (HY-W009538). 5'-Deoxy-5-fluorocytidine (5-Fluoro-5'-deoxycytidine) is a cytidine analog and metabolite of Capecitabine (HY-B0016). 5'-Deoxy-5-fluorocytidine is converted from Capecitabine by carboxylesterase in the liver. 5'-Deoxy-5-fluorocytidine is deaminated by cytidine deaminase to generate 5'-deoxy-5-fluorouridine, which is finally converted into 5-fluorouracil (HY-90006) by thymidine phosphorylase in tumor tissues to exert anti-tumor effects. 5'-Deoxy-5-fluorocytidine is used in the researches for solid tumors such as colorectal cancer, non-small cell lung cancer and breast cancer.
    5'-Deoxy-5-fluorocytidine-<sup>13</sup>C<sub>5</sub>
  • HY-W006057AS2
    3-Methyl-2-oxobutanoic acid-13C4,d4 sodium
    98.0%
    Sodium 3-methyl-2-oxobutanoate-13C4,d4 is the deuterium and 13C labeled Sodium 3-methyl-2-oxobutanoate.
    3-Methyl-2-oxobutanoic acid-<sup>13</sup>C<sub>4</sub>,d<sub>4</sub> sodium
  • HY-W087048S
    2,3-Dichloro-1-propanol-d5
    98.0%
    2,3-Dichloro-1-propanol-d5 is deuterium labeled 2,3-Dichloro-1-propanol.
    2,3-Dichloro-1-propanol-d<sub>5</sub>
  • HY-400850S
    Losartan impurity 15-d9
    Losartan impurity 15-d9 is the deuterium labeled Losartan impurity 15 (HY-400850). Losartan impurity 15 (Formula VI) is a Losartan (HY-17512) impurity containing an azido group.
    Losartan impurity 15-d<sub>9</sub>
  • HY-W746100
    L-Leucic Acid-d3
    L-Leucic Acid-d3 is the deuterium labeled L-Leucic Acid.
    L-Leucic Acid-d<sub>3</sub>
  • HY-U00051AS
    Propiomazine-d6 hydrochloride
    Propiomazine-d6 hydrochloride is deuterium labeled Propiomazine hydrochloride. Propiomazine hydrochloride is an orally active antihistamine agent. Propiomazine hydrochloride is a potent prolactin (PRL) release stimulant, whose effect depends on the antagonism of the dopaminergic system and can inhibit the secretion of luteinizing hormone (LH). Propiomazine hydrochloride is mainly used for anesthesia assistance, mental disorders and anxiety-induced sedation, and can also be used in research related to insomnia.
    Propiomazine-d<sub>6</sub> hydrochloride
  • HY-179982S
    1-Oleoyl-2-linolenoyl-3-chloropropanediol-d5
    1-Oleoyl-2-linolenoyl-3-chloropropanediol-d5 is a deuterated 3-monochloropropanediol (3-MCPD) glycidyl ester.
    1-Oleoyl-2-linolenoyl-3-chloropropanediol-d<sub>5</sub>